Recent studies have highlighted the roles of key enzymes (e.g., HK2 and PKM2) and signaling pathways (e.g., PI3K/Akt/mTOR, c-Myc, HIF-1α) in gastric cancer metabolism. The gene discussed is MTOR; the disease is gastric cancer.